Structural Mechanism of the Pan-BCR-ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibitor Resistance
Version of Record online: 30 NOV 2010
© 2010 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 77, Issue 1, pages 1–11, January 2011
How to Cite
Zhou, T., Commodore, L., Huang, W.-S., Wang, Y., Thomas, M., Keats, J., Xu, Q., Rivera, V. M., Shakespeare, W. C., Clackson, T., Dalgarno, D. C. and Zhu, X. (2011), Structural Mechanism of the Pan-BCR-ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibitor Resistance. Chemical Biology & Drug Design, 77: 1–11. doi: 10.1111/j.1747-0285.2010.01054.x
- Issue online: 7 DEC 2010
- Version of Record online: 30 NOV 2010
- Received 3 September 2010, revised 30 September 2010 and accepted for publication 11 October 2010
Table S1. Activities of ponatinib analogs with full chemical structure (IC50, nM).
|CBDD_1054_sm_TableS1.xls||93K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.